178 related articles for article (PubMed ID: 33157936)
1. The efficacy of baroreflex activation therapy for heart failure: A meta-analysis of randomized controlled trials.
Cai G; Guo K; Zhang D; Qin S
Medicine (Baltimore); 2020 Nov; 99(45):e22951. PubMed ID: 33157936
[TBL] [Abstract][Full Text] [Related]
2. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
[TBL] [Abstract][Full Text] [Related]
3. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
4. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
6. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
7. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
Eur J Heart Fail; 2024 Apr; 26(4):1051-1061. PubMed ID: 38606555
[TBL] [Abstract][Full Text] [Related]
8. Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
Lindenfeld J; Gupta R; Grazette L; Ruddy JM; Tsao L; Galle E; Rogers T; Sears S; Zannad F
JACC Heart Fail; 2021 Jun; 9(6):430-438. PubMed ID: 33992562
[TBL] [Abstract][Full Text] [Related]
9. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
[TBL] [Abstract][Full Text] [Related]
10. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
[TBL] [Abstract][Full Text] [Related]
11. Autonomic regulation device therapy in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Bendary A; Bendary M; Salem M
Heart Fail Rev; 2019 Mar; 24(2):245-254. PubMed ID: 30317416
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Liraglutide for Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
Zhang Y; Chen Q; Huang G; Wang L
Heart Surg Forum; 2019 Oct; 22(6):E438-E444. PubMed ID: 31895026
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
Cui D; Liao Y; Li G; Chen Y
Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review.
Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC
ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Aerobic Exercise on N-terminal Pro-B-type Natriuretic Peptide and Cardiopulmonary Function in Patients With Heart Failure: A Meta-Analysis of Randomised Clinical Trials.
Santoso A; Maulana R; Alzahra F; Prameswari HS; Ambari AM; Hartopo AB; Arso IA; Radi B
Heart Lung Circ; 2020 Dec; 29(12):1790-1798. PubMed ID: 32665172
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials.
Xiang Y; Shi W; Li Z; Yang Y; Wang SY; Xiang R; Feng P; Wen L; Huang W
Medicine (Baltimore); 2019 Mar; 98(13):e14967. PubMed ID: 30921200
[TBL] [Abstract][Full Text] [Related]
17. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
18. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.
Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C
BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774
[TBL] [Abstract][Full Text] [Related]
19. Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.
Ruddy JM; Kroman A; Baicu CF; Zile MR
Heart Fail Clin; 2024 Jan; 20(1):39-50. PubMed ID: 37953020
[TBL] [Abstract][Full Text] [Related]
20. Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure.
Zhou X; Xu W; Xu Y; Qian Z
Am J Med; 2019 Aug; 132(8):955-963. PubMed ID: 30853478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
